May 12, 2020
INOVIO to Present at RBC Capital Markets Virtual Global Healthcare Conference
May 11, 2020
INOVIO Reports First Quarter 2020 Financial Results; Provides Business Update
Mar 30, 2020
INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia
Jan 14, 2020
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement for Treatment of Cervical Dysplasia
Sep 18, 2019
HPV Associated Disorders Market Size Worth $23.2 Billion By 2026: Grand View Research, Inc.
Aug 19, 2019
Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia
Aug 08, 2019
Inovio Pharmaceuticals Reports 2019 Second Quarter Financial Results
Jul 08, 2019
Inovio Completes Enrollment of VGX-3100 Phase 2 Trial for the Treatment of HPV-Related Vulvar Dysplasia (VIN)
Jul 02, 2019
Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®
Jun 26, 2019
Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer
May 06, 2019
Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100
Apr 17, 2019
Inovio's Phase 3 HPV Immunotherapy Selected As "Best Therapeutic Vaccine" at World Vaccine Congress
Apr 08, 2019
Inovio Achieves Third Cancer Indication Milestone for MEDI0457 Phase 2 Development
Mar 04, 2019
Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer
Jan 21, 2019
Global Women's Health Drugs Market to 2024 - Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth
Jul 10, 2018
Antiva Biosciences Closes $15 Million Series C-1 Financing
Mar 21, 2018
GIMDx, Inc. and IncellDx, Inc. Announce Acceleration of Chinese Commercialization of HPV OncoTect Kit
Jan 02, 2018
Naturopathic Doctors Offer Natural Therapies to Treat Cervical Dysplasia and HPV